ClinicalTrials.gg
Sign In
RecruitingNCT06946381CAMPARIUpdated Apr 27, 2025

CAMpania PugliA bRanch Iliaco

An observational study in Aortoiliac Aneurysm and Iliac Aneurysm, sponsored by Federico II University. Recruiting at 2 sites in Italy. Per ClinicalTrials.gov, last updated 2025-04-27.

Sponsored by Federico II University · Observational

From the registry’s dates

  • Primary completion was expected by Jan 2026, 10 months ago, but the record still lists the study as recruiting.
  • Started Jan 2015; still recruiting 11 years 10 months later.
Study type
Observational
Model
Cohort
Time perspective
Prospective
Enrollment
200
Sex
All
01

Study summary

Spontaneus Multicentric Observational registry to investigate the medium and long-term performances of the Iliac E-liac Branch Device from Artivion for treatment of Aortoiliac aneurysms in a real-world consecutive patients cohort.

02

Conditions studied

  • Aortoiliac Aneurysm
  • Iliac Aneurysm

Browse trials for

Keywords

  • evar
  • bevar
  • AAA
03

In context

Iliac Aneurysm

30 studies on the registry are indexed under Iliac Aneurysm; 7 are open to participants now.

This study's planned enrollment of 200 is above the median of 100 across 12 observational studies indexed under Iliac Aneurysm.

Browse Iliac Aneurysm studies →

Lead sponsor

Federico II University is the lead sponsor of 366 studies on the registry; 61 are open to participants now.

Browse Federico II University studies →

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
Child (0–17), Adult (18–64), Older adult (65+)
Sexes eligible
All
Accepts healthy volunteers
No
Sampling method
Non-probability sample

Study population

Patients feferred to the insitution

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • An aortoiliac or aortic aneurysm of surgical interest based on the most recent local guidelines treated with the E-liac stent-graft system, alone or in combination with other devices

Exclusion criteria

Exclusion Criteria:

  • Patient's refusal to be enrolled in the registry
  • Patient treated with devices not including the E-liac stent-graft system
05

Study design

Observational model
Cohort
Time perspective
Prospective
Enrollment
200 participants (estimated)
Patient registry
No

Groups and cohorts

  • MAIN

    Consecutive patients treated with the e-liac device

    Procedure: Evar

Interventions

  • ProcedureEvar

    Branch Evar with the e-liac device

06

What researchers measure

Primary outcomes

  1. Aneurysm related death

    Aneurysm related death

    Time frame: assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five years.

  2. Procedure-related re intervention

    Procedure-related re intervention

    Time frame: assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five years

Secondary outcomes

  1. Aneurysm sac dynamics

    Variation in aneurysm sac diameter

    Time frame: assessed after procedure at 30 days, 6 months, one year, two years, three years, four years, five years

07

Study locations

2 of 2 sites recruiting
08

References and documents

Individual participant data

Plan to share: No

No publications or documents are linked to this record.

09

Updates

Tracking since Sep 25, 2026
No changes since tracking began. The registry record was last updated on Apr 27, 2025, before this site started recording changes on Sep 25, 2026. Its history is on ClinicalTrials.gov ↗
10

Registry details

Key details

Study ID
NCT06946381
Lead sponsor
Federico II University
Collaborators
University of Bari
Responsible party
Umberto Marcello Bracale (Prof., Federico II University) — Principal investigator
First posted
Apr 27, 2025
Start date
Jan 1, 2015
Primary completion
Jan 1, 2026 (estimated)
Completion
Jan 1, 2028 (estimated)
Last update
Apr 27, 2025

Study contacts

Umberto Marcello UM Bracale, PhD, Prof.
Contact
chirurgiavascolarefedericoii@gmail.com
081 746 2629

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
Yes
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Other studies in this condition

Iliac Aneurysm →

Other studies from this sponsor

Federico II University →

Start the discussion